324 related articles for article (PubMed ID: 30622123)
1. Experimental Mutations in Superoxide Dismutase 1 Provide Insight into Potential Mechanisms Involved in Aberrant Aggregation in Familial Amyotrophic Lateral Sclerosis.
Crown AM; Roberts BL; Crosby K; Brown H; Ayers JI; Hart PJ; Borchelt DR
G3 (Bethesda); 2019 Mar; 9(3):719-728. PubMed ID: 30622123
[TBL] [Abstract][Full Text] [Related]
2. Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models.
Crosby K; Crown AM; Roberts BL; Brown H; Ayers JI; Borchelt DR
PLoS One; 2018; 13(11):e0206751. PubMed ID: 30399166
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics of a far positioned SOD1 mutant V14M reveals pathogenic misfolding behavior.
Tompa DR; Kadhirvel S
J Biomol Struct Dyn; 2018 Nov; 36(15):4085-4098. PubMed ID: 29157189
[TBL] [Abstract][Full Text] [Related]
4. The metal cofactor zinc and interacting membranes modulate SOD1 conformation-aggregation landscape in an in vitro ALS model.
Sannigrahi A; Chowdhury S; Das B; Banerjee A; Halder A; Kumar A; Saleem M; Naganathan AN; Karmakar S; Chattopadhyay K
Elife; 2021 Apr; 10():. PubMed ID: 33825682
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states.
Prudencio M; Borchelt DR
Mol Neurodegener; 2011 Nov; 6():77. PubMed ID: 22094223
[TBL] [Abstract][Full Text] [Related]
6. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
[TBL] [Abstract][Full Text] [Related]
7. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells.
Pokrishevsky E; Hong RH; Mackenzie IR; Cashman NR
PLoS One; 2017; 12(9):e0184384. PubMed ID: 28877271
[TBL] [Abstract][Full Text] [Related]
8. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan residue 32 in human Cu-Zn superoxide dismutase modulates prion-like propagation and strain selection.
Crown A; McAlary L; Fagerli E; Brown H; Yerbury JJ; Galaleldeen A; Cashman NR; Borchelt DR; Ayers JI
PLoS One; 2020; 15(1):e0227655. PubMed ID: 31999698
[TBL] [Abstract][Full Text] [Related]
10. Does wild-type Cu/Zn-superoxide dismutase have pathogenic roles in amyotrophic lateral sclerosis?
Furukawa Y; Tokuda E
Transl Neurodegener; 2020 Aug; 9(1):33. PubMed ID: 32811540
[TBL] [Abstract][Full Text] [Related]
11. Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models.
Ayers JI; McMahon B; Gill S; Lelie HL; Fromholt S; Brown H; Valentine JS; Whitelegge JP; Borchelt DR
J Neurochem; 2017 Jan; 140(1):140-150. PubMed ID: 27727458
[TBL] [Abstract][Full Text] [Related]
12. [Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives].
Tokuda E; Marklund SL; Furukawa Y
Yakugaku Zasshi; 2019; 139(7):1015-1019. PubMed ID: 31257248
[TBL] [Abstract][Full Text] [Related]
13. A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis.
Anzai I; Tokuda E; Mukaiyama A; Akiyama S; Endo F; Yamanaka K; Misawa H; Furukawa Y
Protein Sci; 2017 Mar; 26(3):484-496. PubMed ID: 27977888
[TBL] [Abstract][Full Text] [Related]
14. Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis.
Khare SD; Ding F; Dokholyan NV
J Mol Biol; 2003 Nov; 334(3):515-25. PubMed ID: 14623191
[TBL] [Abstract][Full Text] [Related]
15. Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants.
Banerjee V; Shani T; Katzman B; Vyazmensky M; Papo N; Israelson A; Engel S
ACS Chem Neurosci; 2016 Nov; 7(11):1595-1606. PubMed ID: 27540759
[TBL] [Abstract][Full Text] [Related]
16. Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS.
Schmitt ND; Agar JN
J Mass Spectrom; 2017 Jul; 52(7):480-491. PubMed ID: 28558143
[TBL] [Abstract][Full Text] [Related]
17. Nonnative structure in a peptide model of the unfolded state of superoxide dismutase 1 (SOD1): Implications for ALS-linked aggregation.
Cohen NR; Zitzewitz JA; Bilsel O; Matthews CR
J Biol Chem; 2019 Sep; 294(37):13708-13717. PubMed ID: 31341015
[TBL] [Abstract][Full Text] [Related]
18. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
19. Exon 5 encoded domain is not required for the toxic function of mutant SOD1 but essential for the dismutase activity: identification and characterization of two new SOD1 mutations associated with familial amyotrophic lateral sclerosis.
Zu JS; Deng HX; Lo TP; Mitsumoto H; Ahmed MS; Hung WY; Cai ZJ; Tainer JA; Siddique T
Neurogenetics; 1997 May; 1(1):65-71. PubMed ID: 10735277
[TBL] [Abstract][Full Text] [Related]
20. Changes in hydrophobicity mainly promotes the aggregation tendency of ALS associated SOD1 mutants.
Tompa DR; Kadhirvel S
Int J Biol Macromol; 2020 Feb; 145():904-913. PubMed ID: 31669277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
